EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Acoltremon Ophthalmic Solution 0.003% for Symptom Reduction in Dry Eye Disease: Integrated Analysis of the COMET-1, COMET-2, and COMET-3 Studies

Lisa Feulner iD, Jacqueline Theis iD, Mark S Milner iD, James Paauw iD, Kelly K Nichols iD, Michelle Senchyna iD, Selina McGee iD, Jaclyn Garlich iD, Marjan Farid iD

Clinical Ophthalmology · 2026-11 · Volume 20 · 1-12

DOI: 10.2147/opth.s626989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-11. Verfasst von Lisa Feulner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Eye Care & Aesthetics, Bel Air, MD, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SANDESymptom Assessment iN Dry EyeTRPM8 agonistacoltremon 0.003%dry eye disease

Autor:innen und Institutionen

  • Advanced Eye Care & Aesthetics, Bel Air, MD, USA.
  • Virginia Neuro-Optometry, Richmond, VA, USA.
  • Goldman Eye, Palm Beach Gardens, FL, USA.
  • Piedmont Eye Center, Lynchburg, VA, USA.
  • Department of Optometry, School of Optometry, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Alcon Inc, Fort Worth, TX, USA.

ORCID-Profile: Lisa Feulner, Jacqueline Theis, Mark S Milner, James Paauw, Kelly K Nichols, Michelle Senchyna, Selina McGee, Jaclyn Garlich, Marjan Farid

Zitieren

APA

Feulner, L., Theis, J., Milner, M. S., Paauw, J., Nichols, K. K., Senchyna, M., McGee, S., Garlich, J., & Farid, M. (2026). Acoltremon Ophthalmic Solution 0.003% for Symptom Reduction in Dry Eye Disease: Integrated Analysis of the COMET-1, COMET-2, and COMET-3 Studies. Clinical Ophthalmology, Volume 20, 1-12. https://doi.org/10.2147/opth.s626989

Vancouver

Feulner L, Theis J, Milner MS, Paauw J, Nichols KK, Senchyna M, et al. Acoltremon Ophthalmic Solution 0.003% for Symptom Reduction in Dry Eye Disease: Integrated Analysis of the COMET-1, COMET-2, and COMET-3 Studies. Clinical Ophthalmology. 2026;Volume 20:1-12. doi:10.2147/opth.s626989

BibTeX
@article{Feulner2026,
  author = {Feulner, Lisa and Theis, Jacqueline and Milner, Mark S and Paauw, James and Nichols, Kelly K and Senchyna, Michelle and McGee, Selina and Garlich, Jaclyn and Farid, Marjan},
  title = {Acoltremon Ophthalmic Solution 0.003% for Symptom Reduction in Dry Eye Disease: Integrated Analysis of the COMET-1, COMET-2, and COMET-3 Studies},
  journal = {Clinical Ophthalmology},
  year = {2026},
  volume = {Volume 20},
  pages = {1--12},
  doi = {10.2147/opth.s626989}
}
Kostenlos starten →